Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
|
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [31] Impact of serum biomarkers on esophageal squamous cell carcinoma
    Shimada, Hideaki
    Yajima, Satoshi
    Oshima, Yoko
    Hiwasa, Takaki
    Tagawa, Masatoshi
    Matsushita, Kazuyuki
    Nomura, Fumio
    ESOPHAGUS, 2012, 9 (03) : 131 - 140
  • [32] Impact of serum biomarkers on esophageal squamous cell carcinoma
    Hideaki Shimada
    Satoshi Yajima
    Yoko Oshima
    Takaki Hiwasa
    Masatoshi Tagawa
    Kazuyuki Matsushita
    Fumio Nomura
    Esophagus, 2012, 9 : 131 - 140
  • [33] Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
    Mikiko Takikita
    Nan Hu
    Jian-zhong Shou
    Quan-Hong Wang
    Carol Giffen
    Philip R Taylor
    Stephen M Hewitt
    BMC Cancer, 9
  • [34] Circulating micro RNA/isomiRs as novel biomarker of esophageal squamous cell carcinoma
    Ibuki, Yuta
    Tsutani, Yasuhiro
    Ueda, Daisuke
    Koi, Yumiko
    Tahara, Hidetoshi
    Okada, Morihito
    CANCER RESEARCH, 2019, 79 (13)
  • [35] Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma
    Hou, Bo
    Ishinaga, Hajime
    Midorikawa, Kaoru
    Shah, Said Ahmad
    Nakamura, Satoshi
    Hiraku, Yusuke
    Oikawa, Shinji
    Murata, Mariko
    Takeuchi, Kazuhiko
    CANCER BIOLOGY & THERAPY, 2015, 16 (07) : 1042 - 1046
  • [36] Novel Candidate Biomarkers of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma: A Systematic Review
    Sato, Yusuke
    Motoyama, Satoru
    Saito, Hajime
    Minamiya, Yoshihiro
    EUROPEAN SURGICAL RESEARCH, 2016, 56 (3-4) : 141 - 153
  • [37] MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkers
    Wang, Yan
    Zhang, Jinnan
    Zhao, Wei
    Wang, Donglin
    Ma, Wenduan
    Shang, Shengtao
    Feng, Chao
    Yu, Haixin
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 3833 - 3839
  • [38] Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
    Zhang, Mengxue
    Chen, Xiao
    Chen, He
    Zhou, Minyue
    Liu, Yaoqiang
    Hou, Yali
    Nie, Minhai
    Liu, Xuqian
    BIOENGINEERED, 2021, 12 (01) : 8845 - 8862
  • [39] Serum miRNA expression in patients with esophageal squamous cell carcinoma
    Hui, Beina
    Chen, Xin
    Hui, Lingyun
    Xi, Ruxing
    Zhang, Xiaozhi
    ONCOLOGY LETTERS, 2015, 10 (05) : 3008 - 3012
  • [40] Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA
    Ping Yuan
    Xiaoyan Gao
    Mingjun Xu
    Liangyu Qiu
    Zijun Xiong
    Jun Shen
    Huanhuan Xing
    Ruofan Yang
    Liang Zhao
    Xi Liu
    Jiaowei Gu
    Wenting Liu
    Scientific Reports, 14 (1)